Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26397319.
- Also identified by DOI 10.2214/AJR.15.14459.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to provide a comprehensive review of the imaging features of various systemic treatment-related causes of fluid accumulation in cancer patients. Systemic treatment-related fluid accumulation can occur with chemotherapy, molecular targeted therapy, or hematopoietic stem cell transplantation. Imaging findings such as new ascites, pleural and pericardial effusions, and subcutaneous edema should be interpreted with caution on restaging studies.
Medical subject headings
- Antineoplastic Agents
- Diagnostic Imaging
- Edema
- Hematopoietic Stem Cell Transplantation
- Molecular Targeted Therapy
- Neoplasms